This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Chiba-Prefecture. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Hiroki Nagase: Innovator in Targeted Cancer Therapies
Introduction
Hiroki Nagase, an accomplished inventor based in Chiba, Japan, has made significant contributions to the field of targeted cancer therapies. With a focus on developing novel compounds that address genetic mutations involved in cancer, he holds three patents that highlight his innovative spirit and expertise in pharmacology.
Latest Patents
Among his most recent inventions is an alkylating agent designed for specifically targeting driver oncogene mutations. This novel alkylating agent is engineered to bind effectively to the genetic mutation site of a driver oncogene, providing a promising approach for treating various cancers. The patent outlines a complex formed by binding the alkylating agent to a pyrrole imidazole polyamide that specifically binds to the mutation site. Furthermore, it describes a driver oncogene mutation-specific alkylating agent and a pharmaceutical composition that incorporates this complex, highlighting its potential therapeutic applications.
Career Highlights
Hiroki Nagase's career is marked by his dedication to research and development in cancer treatment. His innovative work in designing targeted therapies has placed him at the forefront of medical research aimed at understanding and combating cancer. His commitment to improving patient outcomes through scientific advancements is evident in his patented inventions.
Collaborations
Hiroki collaborates with notable colleagues, including Hiroshi Sugiyama and Toshikazu Bando, within his company based in Chiba-prefecture. Their collective efforts have fostered an environment of creativity and innovation, further pushing the boundaries of what is possible in oncology research.
Conclusion
Hiroki Nagase is a prominent figure in the realm of innovation in cancer therapies, with a particular focus on targeted approaches that directly address genetic factors. His work not only showcases the potential of specialized alkylating agents but also reflects the collaborative spirit that drives advancements in medical science. His contributions through patents continue to pave the way for future innovations in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile